导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 20.05% | 200/1050 |
| 近一周 | -1.98% | 397/1104 |
| 近一月 | -5.31% | 637/1102 |
| 近一季 | -10.97% | 712/1092 |
| 近半年 | 16.62% | 184/1070 |
| 近一年 | 32.69% | 146/1018 |
| 近两年 | 125.84% | 135/926 |
| 近三年 | 79.32% | 126/834 |
| 成立以来 | 95.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.00% 819/1070 |
68.70% 144/1101 |
- - |
- - |
| 2025 | 61.56% 96/1065 |
1.70% 666/1014 |
1.17% 590/1038 |
50.99% 80/1050 |
4.00% 182/1065 |
| 2024 | 1.64% 534/1011 |
-3.37% 501/960 |
-1.70% 420/983 |
7.64% 791/991 |
-0.59% 354/1011 |
| 2023 | -21.72% 713/952 |
-1.15% 674/880 |
-5.82% 570/895 |
-8.65% 535/915 |
-7.96% 754/952 |
| 2022 | -21.09% 372/867 |
-17.08% 365/773 |
7.73% 362/806 |
-12.61% 434/845 |
1.09% 378/867 |
| 2021 | 19.91% 156/740 |
-3.78% 291/580 |
23.15% 112/659 |
1.51% 197/704 |
-0.32% 452/740 |
| 2020 | 99.49% 33/554 |
-4.34% 268/419 |
42.46% 15/466 |
17.43% 90/517 |
24.66% 70/554 |
| 2019 | 32.26% 278/410 |
16.22% 989/1146 |
2.62% 134/1228 |
0.99% 309/390 |
9.82% 166/410 |
| 2018 | -21.28% 95/349 |
- - |
-4.73% 178/990 |
-2.26% 321/1000 |
-8.78% 197/1080 |
| 2017 | -13.76% 201/285 |
- - |
- - |
- - |
- - |
| 2016 | -21.93% 124/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 工银聚焦30股票 VS. 东吴新产业精选股票A(580008) |